Clinicopathological characteristics, treatment patterns and outcomes in patients with HER2-positive breast cancer based on hormone receptor status: a retrospective study

Abstract Background Different hormone receptor (HR) expression patterns have significant biological and therapeutic implications in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, the distinction between HR-positive /HER2-positive (HR+/HER2+) and HR-neg...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Ran Ran, Shidi Zhao, Yan Zhou, Xinyue Hang, Hui Wang, Yuan Fan, Yusi Zhang, Yifan Qiao, Jin Yang, Danfeng Dong
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2024-09-01
Ráidu:	BMC Cancer
Fáttát:	HER2-positive breast cancer Hormone receptor HER2-targeted therapy Endocrine therapy Survival.
Liŋkkat:	https://doi.org/10.1186/s12885-024-12974-4
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!